The story of Viagra and its creator , copyright, presents a tangled picture for potential investors. While the iconic drug initially generated enormous earnings, its protection has expired , leading to competing alternatives flooding the market . This decline in cost presents a real hurdle for copyright and any portfolio considering a heavy holding